According to Acasti Pharma latest financial reports the total debt is $410.00K, an increase of 114.66% to 2022. At the end of 2022 company had $191.00K total debt. This figure represents the debts and financial obligations that Acasti Pharma combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Year | Total debt | Change |
---|---|---|
2023 | $410.00K | 114.66% |
2022 | $191.00K | Infinity% |
2021 | $0 | -100.00% |
2020 | $71.00K | - |